招贤纳士

招贤纳士

RECRUITMENT
Breaking into the billion-dollar diabetes market! Hubei Guangchen secures the first generic version of linagliptin-metformin extended-release tablets.

Breaking into the billion-dollar diabetes market! Hubei Guangchen secures the first generic version of linagliptin-metformin extended-release tablets.

On October 28, 2025, according to an announcement on the official website of the NMPA, the Lixagliptin-Metformin Extended-Release Tablets submitted by Hubei Guangchen Pharmaceutical Co., Ltd. have been approved for marketing (Approval Number: National Drug Approval No. H20255813), making it the first generic version of this dosage form in China. This approval fills a significant gap in the Chinese market for this extended-release formulation and is expected to provide type 2 diabetes patients with a more convenient medication option.

01

2025

/

11

Hubei Guangchen Pharmaceutical Co., Ltd. held a 2025 first-half work summary meeting

Hubei Guangchen Pharmaceutical Co., Ltd. held a 2025 first-half work summary meeting

On July 25, 2025, Hubei Guangchen Pharmaceutical Co., Ltd. held a 2025 first-half work summary meeting. The meeting was presided over by General Manager Chen Shaoyan, and all members of the company's board of directors and managers at the director level and above attended the meeting. Team leaders were also in attendance.

25

2025

/

07

The Unveiling Ceremony for the Yichang Key Laboratory of Green Pharmaceutical Manufacturing was Held

The Unveiling Ceremony for the Yichang Key Laboratory of Green Pharmaceutical Manufacturing was Held

The unveiling ceremony for the Yichang Key Laboratory of Green Manufacturing of Pharmaceuticals was held at the R&D center of Hubei Guangchen Pharmaceutical Co., Ltd. on June 6, 2025.

07

2025

/

06

(Flash) Chairman Lei Shaoqing and General Manager Chen Shaoyan of the company visited the South Korean market.

(Flash) Chairman Lei Shaoqing and General Manager Chen Shaoyan of the company visited the South Korean market.

From April 20 to 25, 2025, Mr. Lei Shaoqing, Chairman of the Board, and Mr. Chen Shaoyan, General Manager, along with Ms. Zhang Hua, Director of Quality, and Mr. Zou Rui, Minister of Safety and Environmental Protection, visited KUKJEON Pharmaceutical Co., Ltd., a South Korean client, for a five-day inspection of the sales situation of Guangchen products in the South Korean market. Through in-depth exchanges with clients and visits to downstream clients, both sides clarified the key points of their next cooperation, and both expressed their willingness to maintain stable cooperation and further expand market share.

28

2025

/

04

Guangchen Pharmaceutical once again becomes a university practice base - A record of the Wuhan Institute of Technology (Hubei Guangchen Pharmaceutical Co., Ltd.) labor and practice base inauguration ceremony

Guangchen Pharmaceutical once again becomes a university practice base - A record of the Wuhan Institute of Technology (Hubei Guangchen Pharmaceutical Co., Ltd.) labor and practice base inauguration ceremony

On March 12, 2025, Vice President Yu Xianglin and Professor Yan Fuan, a secondary professor from the School of Chemical Engineering and Pharmacy at Wuhan University of Technology, paid a special visit to our company. A ceremony was held in the company's first-floor lobby to officially designate Hubei Guangchen Pharmaceutical Co., Ltd. as a labor and practice base. Mr. Chen Shaoyan, General Manager of the company, attended the ceremony.

12

2025

/

03

Hubei Guangchen Pharmaceutical held a grand commendation conference for the year 2024.

Hubei Guangchen Pharmaceutical held a grand commendation conference for the year 2024.

On January 25, 2025, Hubei Guangchen Pharmaceutical Co., Ltd. held a grand award ceremony to honor the outstanding employees and outstanding teams of the year 2024.

05

2025

/

02

Hubei Guangchen Pharmaceutical Co., Ltd. grandly held its 2024 annual work summary meeting

Hubei Guangchen Pharmaceutical Co., Ltd. grandly held its 2024 annual work summary meeting

On January 18, 2025, Hubei Guangchen Pharmaceutical Co., Ltd. grandly held its 2024 annual work summary meeting.

03

2025

/

02

Experts from the Hubei Provincial Office for the Prohibition of Chemical Weapons visited Guangchen Pharmaceutical for inspection and guidance on December 27, 2024.

Experts from the Hubei Provincial Office for the Prohibition of Chemical Weapons visited Guangchen Pharmaceutical for inspection and guidance on December 27, 2024.

Experts from the Hubei Provincial Chemical Weapons Prohibition Office visited Guangchen Pharmaceutical for inspection and guidance on December 27, 2024.

31

2024

/

12

< 1234 >